SCHEMBL6213112

SCHEMBL6213112

COc1cc2ncn(-c3cc(OCc4ccc(F)cc4Cl)c(C(=O)O)s3)c2cc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 19/20 0.68
PLK3 Q9H4B4 3/20 0.68
PLK4 O00444 2/20 0.68
AURKA O14965 2/20 0.68
JAK2 O60674 2/20 0.68
LCK P06239 2/20 0.68
CSF1R P07333 2/20 0.68
FGFR1 P11362 2/20 0.68
SRC P12931 2/20 0.68
FLT1 P17948 2/20 0.68
CDK2 P24941 2/20 0.68
AXL P30530 2/20 0.68
FLT4 P35916 2/20 0.68
KDR P35968 2/20 0.68
GSK3B P49841 2/20 0.68
NEK2 P51955 2/20 0.68
JAK3 P52333 2/20 0.68
LIMK1 P53667 2/20 0.68
STK3 Q13188 2/20 0.68
DYRK1A Q13627 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058228 0.92 PLK1 (0.66) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5058177 0.88 PLK1 (0.59) PLK1PLK3PLK4AURKAJAK2
SCHEMBL4034945 0.82 PLK1 (0.78) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5062148 0.82 PLK1 (0.59) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5067346 0.81 PLK1 (0.85) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5058278 0.81 PLK1 (1.00) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5065696 0.80 PLK1 (0.59) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5062883 0.78 PLK1 (0.68) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5062393 0.78 PLK1 (0.68) PLK1PLK3PLK4AURKAJAK2
SCHEMBL5058138 0.77 PLK1 (0.88) PLK1PLK3PLK4AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546137-A1 BENZIMIDAZOL-1-YL-THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER SmithKline Beecham Corporation (US) 2005-06-29 EP disclosed
WO-2004014899-A1 THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-19 WO disclosed